Aurobindo gets FDA nod for Cyclobenzaprine

Drug firm Aurobindo Pharma has received US Food and Drug Administration (USFDA) approval for marketing Cyclobenzaprine hydrochloride tablets, most widely prescribed as a muscle relaxant.

By PTI | Sep 29, 2008, 02.13 PM IST

NEW DELHI: Drug firm Aurobindo Pharma has received US Food and Drug Administration (USFDA) approval for marketing Cyclobenzaprine hydrochloride tablets, most widely prescribed as a muscle relaxant.

The company has got the approval to market and distribute the drug in 10 mg and 5 mg strengths, according to the information available on the website of USFDA.

Aurobindo Pharma is a Hyderabad-based pharmaceutical manufacturer.

Start a SIP with as low as ₹500 with ET Money App!